FOCUS: Feasibility, Acceptability, and Pilot of an Intervention to Improve Functioning in Adolescents With Sickle Cell Disease and Cancer

Study point of contact

Lindsey L Cohen, PhD
404-413-6263
[email protected]
Laura G McKee, PhD
802-5789075
[email protected]

Locations

2 United States sites

Age

12 to 18 Years

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Behavioral

Compensation


Notice: Undefined variable: amount in /var/www/sc101/wp-content/themes/sc101/tpl-parts/study-content.php on line 108

Unknown

About the study

Aim. Pilot FOCUS. A pilot randomized controlled trial will compare FOCUS to standard care.
Investigators will randomize a total of 60 12- to 18-year-old patients to either FOCUS
intervention (n=15 with SCD; n=15 with cancer) or treatment as usual (n=15 with SCD; n=15
with cancer). Randomization will be stratified to match patients based on age, sex, and
medical condition (SCD type, cancer type). FOCUS participants will engage in the intervention
and complete measures for 10 days post hospital discharge. Control participants will complete
similar measures but not receive the intervention. Mixed qualitative and quantitative
measures of feasibility, acceptability, and preliminary outcomes will be conducted to
evaluate both the intervention and study procedures.

study participation requirements

– 1) diagnosis of sickle cell disease, any hemoglobin type or diagnosis of leukemia,
lymphoma, or solid tumor

– 2) inpatient at CHOA

– 3) 12-18 years of age

– 4) English speaking

– 5) owns a smartphone with camera.

study participation exclusions

– 1) report of active psychosis or active suicidal ideation in the adolescents

– 2) significant documented developmental delay, autism spectrum disorder, or
significant intellectual impairment, as these comorbidities may confound the study
aims by impacting the dependent measures.

Location

  • Georgia State University, Atlanta, Georgia, United States, 30302 [Not yet recruiting]
  • Children's Healthcare of Atlanta, Atlanta, Georgia, United States, 30342 [Not yet recruiting]

More info

View on ClinicalTrials.gov
Site is under construction